Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $1.01 - 0.11 (0.00%)
ExchangeNASDAQ GS
Volume199,190
Today's Open$1.11
Previous Close$1.01
Data as of 03/21/19 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $1.01 with a 52 week high of $3.69 and a 52 week low of $0.48.
Recent News

March 18, 2019

NantHealth® and Northwest Fire Fighters Benefits Trust (NWFFT) Join Forces to Provide GPS Cancer® and Liquid GPS to Trust Covered Members

CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 18, 2019-- NantHealth, Inc. (NASDAQ: NH), announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one of the largest firefighter healthcare trusts in the U.S., to ensure all NWFFT covered plan members with access to NantHealth’s GPS Cancer and Liquid GPS molecular profiling tests. Comprehensive molecular information may enable physicians to make personalized treatment strategies for cancer ba...

Read More >

February 14, 2019

NantHealth® and NantOmics to Reveal New Research Demonstrating Importance of Examining RNA Expression and Individual Biomarkers in Cancer Testing

Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium SAN FRANCISCO & CULVER CITY, Calif.--(BUSINESS WIRE)--Feb. 14, 2019-- Scientific teams from NantHealth (NASDAQ: NH) and NantOmics will present two posters at the American Society of Clinical Oncology’s (ASCO) Genitourinary Cancers Symposium this week. The two companies, respective leaders in molecular profiling research and g...

Read More >

February 12, 2019

NantHealth® Debuts Multiple Connected Care Initiatives at HIMSS

Collaboration with Leading Kidney Care Vendors, Intelligent Health and Connected Care Showcased CULVER CITY, Calif. & ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 12, 2019-- NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, will unveil a series of new initiatives designed to improve patient outcomes and provider satisfaction at the 2019 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition ...

Read More >

Upcoming Events
There are currently no events scheduled.